Paola Signorelli

Title: Paola Signorelli: Innovator in Cardiac Treatment

Introduction

Paola Signorelli is a distinguished inventor based in Legnano, Italy. She has made significant contributions to the field of cardiac health through her innovative research and patenting efforts. Her work focuses on methods for treating cardiac reperfusion injury, a critical area in cardiovascular medicine.

Latest Patents

Signorelli holds a patent for "Methods for treating cardiac reperfusion injury." This groundbreaking invention stems from her surprising discovery regarding ceramide production during reperfusion injury in the heart. She found that upregulation of ceramide production occurs through the de novo ceramide synthesis pathway. By treating cardiac tissues subjected to reperfusion injury with myriocin, a specific inhibitor of this pathway, she demonstrated that inflammation is reduced, infarct size is minimized, cardiac contractility is improved, and cell detoxification and survival programs are activated. This patent provides a novel approach to treating cardiac reperfusion injury.

Career Highlights

Throughout her career, Paola Signorelli has worked with prestigious institutions, including Università degli Studi di Milano and Policlinico San Donato S.p.a. Her research has garnered attention for its innovative approach to addressing critical health issues related to cardiac function.

Collaborations

Signorelli has collaborated with notable colleagues, including Riccardo Ghidoni and Luigi Anastasia. Their combined expertise has contributed to the advancement of research in cardiac health and treatment methodologies.

Conclusion

Paola Signorelli's contributions to the field of cardiac treatment through her innovative patent highlight her role as a leading inventor. Her work not only enhances our understanding of cardiac reperfusion injury but also paves the way for new therapeutic strategies.